![Jeanne Jew](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeanne Jew
Plus aucun poste en cours
Profil
Jeanne Y.
Jew worked as a Director at Catalyst Biosciences, Inc. from 2021 to 2022.
Prior to that, she held positions as a Principal at Genentech, Inc. and Scios, Inc. From 2002 to 2007, she served as the VP-Corporate & Commercial Development at Onyx Pharmaceuticals, Inc. Before that, she was the Vice President-Business Development at Coulter Pharmaceuticals, Inc. from 1997 to 2001.
She also held the position of Vice President-Business Development at Deltagen, Inc. from 2001 to 2002.
From 2008 to 2015, she worked as the Senior Vice President-Business Development at Humanigen, Inc. and from 2015 to 2020, she held the same position at Paratek Pharmaceuticals, Inc. Currently, she is the Chief Business Officer at ALX Oncology Holdings, Inc. Ms. Jew holds an MBA from Cornell University and an undergraduate degree from Wesleyan University.
Anciens postes connus de Jeanne Jew
| Sociétés | Poste | Fin |
|---|---|---|
| CATALYST BIOSCIENCES | Directeur/Membre du Conseil | 26/12/2022 |
| PARATEK PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/03/2020 |
| HUMANIGEN, INC. | Corporate Officer/Principal | 01/07/2015 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | - |
| DELTAGEN INC. | Corporate Officer/Principal | 01/11/2002 |
Formation de Jeanne Jew
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
64
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Scios, Inc.
 Scios, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures & commercializes pharmaceuticals | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Coulter Pharmaceuticals, Inc.
 Coulter Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs and therapies for treatment of cancer | Health Technology |
Deltagen, Inc.
 Deltagen, Inc. Miscellaneous Commercial ServicesCommercial Services Provides drug discovery tools and services to the biopharmaceutical industry | Commercial Services |
Humanigen, Inc.
 Humanigen, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that engages in development of cell and gene therapies for treatment of cancers and infectious diseases | Health Technology |
Cornell University
 Cornell University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Wesleyan University
 Wesleyan University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Paratek Pharmaceuticals, Inc.
 Paratek Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals | Health Technology |
Catalyst Biosciences, Inc.
 Catalyst Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical stage biopharmaceutical company | Health Technology |
ALX Oncology Holdings, Inc.
 ALX Oncology Holdings, Inc. BiotechnologyHealth Technology Operates as clinical stage immuno-oncology company, which develops therapies for cancer | Health Technology |
